Daphne Sawlwin

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Terry Nolan, Peter Richmond, Neil Formica et al. · Vaccine · 2008 · 89 citations

Vaccination, Cross-protection, Vaccine Development +8

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Humberto Reynales, Airi Põder, Charles Yu et al. · The Lancet Infectious Diseases · 2021 · 46 citations

Vaccination, Vaccine Safety, Preventive Medicine +10

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study

John Treanor, Frank R. Albano, Daphne Sawlwin et al. · Vaccine · 2017 · 34 citations · Full text

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children

Rebecca C. Brady, Wilson Hu, Vonda G. Houchin et al. · Vaccine · 2014 · 16 citations

Vaccination, Vaccine Safety, Cross-protection +9

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6–59 months of age: A phase 3, randomized, noninferiority study

Victoria A. Statler, Frank R. Albano, Jolanta Airey et al. · Vaccine · 2018 · 16 citations · Full text